Search results
Results From The WOW.Com Content Network
In June 2023, Viatris was named to the Forbes Global 2000 list of the world's largest companies. [24] In October 2023, Viatris reached agreements to divest from almost all of its OTC business, its women’s healthcare business, and its India-based active pharmaceutical ingredients business for a total of about $3.6 billion. [25]
Lynch had served as CEO since 2021 and led the company through the Covid-19 pandemic, overseeing the rollout of in-store vaccinations. Under her tenure, the company also acquired Signify Health ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Takeda Pharmaceutical: Shire: 61 74 Second bid, unanimously rejected by the Shire Board, who concluded that it significantly undervalue the company, its growth prospects as well as pipeline. [24] 12 2018 Takeda Pharmaceutical: Shire: 58.2 71
Dec. 2—Pfizer Inc. is starting to roll out the pharmaceutical company's biggest round of layoffs since 2009, and its Groton laboratories are not immune. Of course, New York-based Pfizer these ...
February 20, 2025 at 8:17 AM. In the weeks since President Donald Trump has assumed office, more than 200,000 federal workers at more than a dozen agencies have had their roles eliminated.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, [3] with production facilities in nine countries and affiliates or offices in five. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.